<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>6(1)</volume><submitter>Truxova I</submitter><pubmed_abstract>A high density of tumor-infiltrating CD8&lt;sup>+&lt;/sup> T cells and CD20&lt;sup>+&lt;/sup> B cells correlates with prolonged survival in patients with a wide variety of human cancers, including high-grade serous ovarian carcinoma (HGSC). However, the potential impact of mature dendritic cells (DCs) in shaping the immune contexture of HGSC, their role in the establishment of T cell-dependent antitumor immunity, and their potential prognostic value for HGSC patients remain unclear. We harnessed immunohistochemical tests and biomolecular analyses to demonstrate that a high density of tumor-infiltrating DC-LAMP&lt;sup>+&lt;/sup> DCs is robustly associated with an immune contexture characterized by T&lt;sub>H&lt;/sub>1 polarization and cytotoxic activity. We showed that both mature DCs and CD20&lt;sup>+&lt;/sup> B cells play a critical role in the generation of a clinically-favorable cytotoxic immune response in HGSC microenvironment. In line with this notion, robust tumor infiltration by both DC-LAMP&lt;sup>+&lt;/sup> DCs and CD20&lt;sup>+&lt;/sup> B cells was associated with most favorable overall survival in two independent cohorts of chemotherapy-naïve HGSC patients. Our findings suggest that the presence of mature, DC-LAMP&lt;sup>+&lt;/sup> DCs in the tumor microenvironment may represent a novel, powerful prognostic biomarker for HGSC patients that reflects the activation of clinically-relevant anticancer immunity.</pubmed_abstract><journal>Journal for immunotherapy of cancer</journal><pagination>139</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6288908</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.</pubmed_title><pmcid>PMC6288908</pmcid><pubmed_authors>Ryska A</pubmed_authors><pubmed_authors>Hensler M</pubmed_authors><pubmed_authors>Rob L</pubmed_authors><pubmed_authors>Sautes-Fridman C</pubmed_authors><pubmed_authors>Fucikova J</pubmed_authors><pubmed_authors>Skapa P</pubmed_authors><pubmed_authors>Pecen L</pubmed_authors><pubmed_authors>Truxova I</pubmed_authors><pubmed_authors>Praznovec I</pubmed_authors><pubmed_authors>Kodet R</pubmed_authors><pubmed_authors>Spisek R</pubmed_authors><pubmed_authors>Kasikova L</pubmed_authors><pubmed_authors>Brtnicky T</pubmed_authors><pubmed_authors>Goc J</pubmed_authors><pubmed_authors>Galluzzi L</pubmed_authors><pubmed_authors>Belicova L</pubmed_authors><pubmed_authors>Halaska MJ</pubmed_authors><pubmed_authors>Fridman WH</pubmed_authors><pubmed_authors>Laco J</pubmed_authors><pubmed_authors>Salkova E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.</name><description>A high density of tumor-infiltrating CD8&lt;sup>+&lt;/sup> T cells and CD20&lt;sup>+&lt;/sup> B cells correlates with prolonged survival in patients with a wide variety of human cancers, including high-grade serous ovarian carcinoma (HGSC). However, the potential impact of mature dendritic cells (DCs) in shaping the immune contexture of HGSC, their role in the establishment of T cell-dependent antitumor immunity, and their potential prognostic value for HGSC patients remain unclear. We harnessed immunohistochemical tests and biomolecular analyses to demonstrate that a high density of tumor-infiltrating DC-LAMP&lt;sup>+&lt;/sup> DCs is robustly associated with an immune contexture characterized by T&lt;sub>H&lt;/sub>1 polarization and cytotoxic activity. We showed that both mature DCs and CD20&lt;sup>+&lt;/sup> B cells play a critical role in the generation of a clinically-favorable cytotoxic immune response in HGSC microenvironment. In line with this notion, robust tumor infiltration by both DC-LAMP&lt;sup>+&lt;/sup> DCs and CD20&lt;sup>+&lt;/sup> B cells was associated with most favorable overall survival in two independent cohorts of chemotherapy-naïve HGSC patients. Our findings suggest that the presence of mature, DC-LAMP&lt;sup>+&lt;/sup> DCs in the tumor microenvironment may represent a novel, powerful prognostic biomarker for HGSC patients that reflects the activation of clinically-relevant anticancer immunity.</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Dec</publication><modification>2026-05-05T22:23:34.277Z</modification><creation>2019-03-27T00:11:53Z</creation></dates><accession>S-EPMC6288908</accession><cross_references><pubmed>30526667</pubmed><doi>10.1186/s40425-018-0446-3</doi></cross_references></HashMap>